Bette Jacobs - Dec 29, 2022 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role
Director
Signature
/s/ Bette Jacobs
Stock symbol
SHPH
Transactions as of
Dec 29, 2022
Transactions value $
-$7,007
Form type
4
Date filed
1/3/2023, 05:10 AM
Previous filing
Nov 9, 2022
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHPH CLASS A COMMON STOCK Sale -$7.01K -4.37K -12.27% $1.61 31.2K Dec 29, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 11,862 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
F2 Consists of 7,496 shares of SHPH common stock and 23,725 RSUs, with each RSU representing the right to receive one share of SHPH common stock upon vesting, which RSUs remain subject to certain vesting conditions.